BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12972414)

  • 1. The adenosine analog tubercidin inhibits glycolysis in Trypanosoma brucei as revealed by an RNA interference library.
    Drew ME; Morris JC; Wang Z; Wells L; Sanchez M; Landfear SM; Englund PT
    J Biol Chem; 2003 Nov; 278(47):46596-600. PubMed ID: 12972414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1.
    Chambers JW; Fowler ML; Morris MT; Morris JC
    Mol Biochem Parasitol; 2008 Apr; 158(2):202-7. PubMed ID: 18262292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycolysis modulates trypanosome glycoprotein expression as revealed by an RNAi library.
    Morris JC; Wang Z; Drew ME; Englund PT
    EMBO J; 2002 Sep; 21(17):4429-38. PubMed ID: 12198145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the role of compartmentation of glycolysis in procyclic form Trypanosoma brucei: RNA interference studies of PEX14, hexokinase, and phosphofructokinase.
    Kessler PS; Parsons M
    J Biol Chem; 2005 Mar; 280(10):9030-6. PubMed ID: 15637070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibitors for the glycolytic enzymes of Trypanosoma brucei.
    Trinquier M; Perie J; Callens M; Opperdoes F; Willson M
    Bioorg Med Chem; 1995 Nov; 3(11):1423-7. PubMed ID: 8634823
    [No Abstract]   [Full Text] [Related]  

  • 6. Compartmentation of phosphoglycerate kinase in Trypanosoma brucei plays a critical role in parasite energy metabolism.
    Blattner J; Helfert S; Michels P; Clayton C
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11596-600. PubMed ID: 9751711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What controls glycolysis in bloodstream form Trypanosoma brucei?
    Bakker BM; Michels PA; Opperdoes FR; Westerhoff HV
    J Biol Chem; 1999 May; 274(21):14551-9. PubMed ID: 10329645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and in silico analyses of glycolytic flux control in bloodstream form Trypanosoma brucei.
    Albert MA; Haanstra JR; Hannaert V; Van Roy J; Opperdoes FR; Bakker BM; Michels PA
    J Biol Chem; 2005 Aug; 280(31):28306-15. PubMed ID: 15955817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity.
    Hulpia F; Campagnaro GD; Scortichini M; Van Hecke K; Maes L; de Koning HP; Caljon G; Van Calenbergh S
    Eur J Med Chem; 2019 Feb; 164():689-705. PubMed ID: 30677668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters.
    Schumann Burkard G; Jutzi P; Roditi I
    Mol Biochem Parasitol; 2011 Jan; 175(1):91-4. PubMed ID: 20851719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose is toxic to glycosome-deficient trypanosomes.
    Furuya T; Kessler P; Jardim A; Schnaufer A; Crudder C; Parsons M
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14177-82. PubMed ID: 12386344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of various metabolic conditions and of the trivalent arsenical melarsen oxide on the intracellular levels of fructose 2,6-bisphosphate and of glycolytic intermediates in Trypanosoma brucei.
    Van Schaftingen E; Opperdoes FR; Hers HG
    Eur J Biochem; 1987 Aug; 166(3):653-61. PubMed ID: 3038548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New functions for parts of the Krebs cycle in procyclic Trypanosoma brucei, a cycle not operating as a cycle.
    van Weelden SW; van Hellemond JJ; Opperdoes FR; Tielens AG
    J Biol Chem; 2005 Apr; 280(13):12451-60. PubMed ID: 15647263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma brucei brucei: the catabolism of glycolytic intermediates by digitonin-permeabilized bloodstream trypomastigotes and some aspects of regulation of anaerobic glycolysis.
    Kiaira JK; Njogu RM
    Int J Biochem; 1988; 20(10):1165-70. PubMed ID: 3248672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Atypical Mitochondrial Carrier That Mediates Drug Action in Trypanosoma brucei.
    de Macêdo JP; Schumann Burkard G; Niemann M; Barrett MP; Vial H; Mäser P; Roditi I; Schneider A; Bütikofer P
    PLoS Pathog; 2015 May; 11(5):e1004875. PubMed ID: 25946070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs.
    Bakker BM; Westerhoff HV; Opperdoes FR; Michels PA
    Mol Biochem Parasitol; 2000 Feb; 106(1):1-10. PubMed ID: 10743606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycolysis in Trypanosoma brucei.
    Visser N; Opperdoes FR
    Eur J Biochem; 1980 Feb; 103(3):623-32. PubMed ID: 6766864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a nucleoside/proton symporter in procyclic Trypanosoma brucei brucei.
    de Koning HP; Watson CJ; Jarvis SM
    J Biol Chem; 1998 Apr; 273(16):9486-94. PubMed ID: 9545276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolytic enzymes of Trypanosoma brucei. Simultaneous purification, intraglycosomal concentrations and physical properties.
    Misset O; Bos OJ; Opperdoes FR
    Eur J Biochem; 1986 Jun; 157(2):441-53. PubMed ID: 2940090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the hexokinase/hexose transporter region in the glycosomal membrane of bloodstream Trypanosoma brucei by oligomycin and digitonin.
    Njogu MR; Kiaira JK
    Indian J Biochem Biophys; 2004 Dec; 41(6):329-32. PubMed ID: 22900363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.